Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy

Sujith Samarasinghe, Christoph Mancao, Martin Pule, Niga Nawroly, Helen Karlsson, Jennifer Brewin, Peter Openshaw, H. Bobby Gaspar, Paul Veys, Persis J. Amrolia

Blood (2010) 115 (2): 396–407.

https://doi.org/10.1182/blood-2009-08-235895

Published: 2010

Includes: Supplemental data

Journal Articles

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

Jennifer Brewin, Christoph Mancao, Karin Straathof, Helen Karlsson, Sujith Samarasinghe, Persis J. Amrolia, Martin Pule

Blood (2009) 114 (23): 4792–4803.

https://doi.org/10.1182/blood-2009-07-228387

Published: 2009

Includes: Supplemental data

Journal Articles

A Novel Strategy to Render CTL Resistant to Immunosuppression with Calcineurin Inhibitors

Jennifer Brewin, Karin Straathof, Helen Karlsson, Cristoph Mancao, Barbara Savoldo, Gianpietro Dotti, Martin Pule, Persis Amrolia

Blood (2008) 112 (11): 3897.

https://doi.org/10.1182/blood.V112.11.3897.3897

Published: 2008

Journal Articles

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Helen Karlsson, Sujith Samarasinghe, Lynne M. Ball, Berit Sundberg, Arjan C. Lankester, Francesco Dazzi, Mehmet Uzunel, Kanchan Rao, Paul Veys, Katarina Le Blanc, Olle Ringdén, Persis J. Amrolia

Blood (2008) 112 (3): 532–541.

https://doi.org/10.1182/blood-2007-10-119370

Published: 2008

Journal Articles

Functional Characterisation of Alloreactive T-Cells Identifies CD25 and CD71 as the Optimal Targets for Allodepletion Strategies.

Sujith R. Samarasinghe, MRCPCH, Niga Nawroly, B.Sc, Helen Karlsson, PhD, Peter Openshaw, FMedSci, PhD, Ellen Vitteta, PhD, Paul Veys, FRCP, Persis Amrolia, FRCP, PhD

Blood (2007) 110 (11): 2183.

https://doi.org/10.1182/blood.V110.11.2183.2183

Published: 2007

NARROW

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

A Novel Strategy to Render CTL Resistant to Immunosuppression with Calcineurin Inhibitors

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Functional Characterisation of Alloreactive T-Cells Identifies CD25 and CD71 as the Optimal Targets for Allodepletion Strategies.

Email alerts

ASH Publications

American Society of Hematology

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

A Novel Strategy to Render CTL Resistant to Immunosuppression with Calcineurin Inhibitors

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Functional Characterisation of Alloreactive T-Cells Identifies CD25 and CD71 as the Optimal Targets for Allodepletion Strategies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only